Cellectis SA
PAR:ALCLS
Cellectis SA
PAR:ALCLS
Price:
2.825
EUR
-0.88%
Market Closed
Market Cap:
€203.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cellectis SA
PAR:ALCLS
|
FR |
|
S
|
Sun Vending Technology PCL
SET:SVT
|
TH |
|
Iskenderun Demir ve Celik AS
IST:ISDMR.E
|
TR |
|
Constellation Resources Ltd
ASX:CR1
|
AU |
|
A
|
Asdion Bhd
KLSE:ASDION
|
MY |
|
R
|
Rockworth PCL
SET:ROCK
|
TH |
|
Vardhman Polytex Ltd
NSE:VARDMNPOLY
|
IN |
|
Jindal Poly Films Ltd
NSE:JINDALPOLY
|
IN |
|
W
|
Winshine Science Co Ltd
HKEX:209
|
HK |
|
W
|
West China Cement Ltd
HKEX:2233
|
CN |
|
Saregama India Ltd
BSE:532163
|
IN |
|
FCS Software Solutions Ltd
NSE:FCSSOFT
|
IN |
|
Creative Vistas Inc
OTC:CVAS
|
CA |
|
S
|
Shakey's Pizza Asia Ventures Inc
XPHS:PIZZA
|
PH |
|
K
|
Kardan Israel Ltd
TASE:KRDI
|
IL |
|
DG Innovate PLC
LSE:DGI
|
UK |
|
O
|
OpenWork Inc
TSE:5139
|
JP |
|
FNB Corp
NYSE:FNB
|
US |
|
V
|
Village Farms International Inc
NASDAQ:VFF
|
CA |
|
AEye Inc
NASDAQ:LIDR
|
US |
|
Triton International Ltd
F:TR7
|
BM |
Multiples-Based Value
The Multiples-Based Value of one
ALCLS
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 2.825 EUR,
Cellectis SA
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALCLS Multiples-Based Value
LOCKED
Multiples Across Competitors
ALCLS Competitors Multiples
Cellectis SA Competitors
Cellectis SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Cellectis SA
PAR:ALCLS
|
204.4m EUR | 3 | -3.5 | -10 | -3.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD | 6.1 | 88.4 | 14.7 | 20.4 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD | 109.4 | -1 708.3 | 15 870 | -1 791.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD | 5.7 | 19.6 | 12.3 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD | 9.2 | 27.8 | 20.9 | 21.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD | 3.2 | 35.1 | 11.5 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
